114 related articles for article (PubMed ID: 9697032)
21. In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa.
Díez Enciso M
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):90-2. PubMed ID: 1907544
[No Abstract] [Full Text] [Related]
22. Comparison of two techniques for measurement of in vitro killing kinetics of five antibiotics against Pseudomonas aeruginosa.
Lesage D; Delisle F; Richard G; Burghoffer B; Le Cunff D; Petit JC
Eur J Clin Microbiol Infect Dis; 1994 May; 13(5):412-7. PubMed ID: 8070456
[TBL] [Abstract][Full Text] [Related]
23. Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters.
Reid G; Sharma S; Advikolanu K; Tieszer C; Martin RA; Bruce AW
Antimicrob Agents Chemother; 1994 Jul; 38(7):1490-5. PubMed ID: 7979277
[TBL] [Abstract][Full Text] [Related]
24. Modulation of biofilms of Pseudomonas aeruginosa by quinolones.
Yassien M; Khardori N; Ahmedy A; Toama M
Antimicrob Agents Chemother; 1995 Oct; 39(10):2262-8. PubMed ID: 8619580
[TBL] [Abstract][Full Text] [Related]
25. Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria.
Cernohorská L; Votava M
Folia Microbiol (Praha); 2004; 49(1):75-8. PubMed ID: 15114870
[TBL] [Abstract][Full Text] [Related]
26. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
27. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Ansorg R; Müller KD; Wiora J
Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878
[TBL] [Abstract][Full Text] [Related]
28. [Release of DNA from Pseudomonas aeruginosa in vitro during spontaneous growth and treatment with ciprofloxacin].
Peng DZ; Guymon CH; McManus AT; Xiao GX
Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):178-81. PubMed ID: 15842899
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.
Kresken M; Körber-Irrgang B; Läuffer J; Decker-Burgard S; Davies T
Int J Antimicrob Agents; 2011 Jul; 38(1):70-5. PubMed ID: 21514795
[TBL] [Abstract][Full Text] [Related]
30. The effects of D-Tyrosine combined with amikacin on the biofilms of Pseudomonas aeruginosa.
She P; Chen L; Liu H; Zou Y; Luo Z; Koronfel A; Wu Y
Microb Pathog; 2015 Sep; 86():38-44. PubMed ID: 26188263
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.
Friedland I; Gallagher G; King T; Woods GL
J Chemother; 2004 Oct; 16(5):437-41. PubMed ID: 15565908
[TBL] [Abstract][Full Text] [Related]
32. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
Gerçeker AA; Gürler B
J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
[TBL] [Abstract][Full Text] [Related]
33. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
Chan E; Zhou S; Srikumar S; Duan W
Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial activity of liposome-encapsulated antibiotics against Pseudomonas aeruginosa attached to the matrix of human dermis.
Trafny EA; Antos-Bielska M; Grzybowski J
J Microencapsul; 1999; 16(4):419-29. PubMed ID: 10420328
[TBL] [Abstract][Full Text] [Related]
35. [The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Sener B; Hayran M; Kocagöz T; Ustaçelebi S
Mikrobiyol Bul; 1990 Apr; 24(2):120-5. PubMed ID: 2128529
[TBL] [Abstract][Full Text] [Related]
36. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
[TBL] [Abstract][Full Text] [Related]
38. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.
Bonfiglio G; Carciotto V; Russo G; Stefani S; Schito GC; Debbia E; Nicoletti G
J Antimicrob Chemother; 1998 Feb; 41(2):307-10. PubMed ID: 9533479
[TBL] [Abstract][Full Text] [Related]
40. Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains.
Wojnicz D; Kłak M; Adamski R; Jankowski S
Folia Microbiol (Praha); 2007; 52(4):429-36. PubMed ID: 18062193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
